H.R. 5334 · 112th Congress
To amend chapter V of the Federal Food, Drug, and Cosmetic Act to expedite the development and review of breakthrough therapies.
- Stage
- In committee
- Sponsor
- Brian Bilbray
- Introduced
- 2012-05-07
- Latest action
- 2012-05-11 · Referred to the Subcommittee on Health.
Subjects
Administrative law and regulatory procedures
Congressional oversight
Health
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Food and Drug Administration (FDA)